Weixinkang announced that its wholly-owned subsidiary Baiyi Pharmaceutical has received the Drug Registration Certificate for Water-Soluble Vitamins for Injection issued by the National Medical Products Administration. The specification is compound, the registration classification is chemical drug category 3, and it is deemed to have passed consistency evaluation. This drug is an indispensable component of parenteral nutrition, used to meet the daily physiological needs of adults and children for water-soluble vitamins. The announcement shows that the company's cumulative R&D investment is approximately 8.03 million yuan, unaudited. Weixinkang stated that it has begun pre-launch preparations, but future sales are subject to uncertainty due to factors such as the market environment and bidding.
Tibet Weixinkang Medicine Co LtdWholly-owned subsidiary Baiyi Pharmaceutical received a Drug Registration Certificate for Water-Soluble Vitamins for Injection, a new product approval.
Baiyi Pharmaceutical received the Drug Registration Certificate for Water-Soluble Vitamins for Injection from the NMPA.
